SEC 13F Intelligence

Cambridge Financial Group, Inc. / ABBV

Cambridge Financial Group, Inc.’s Abbvie Inc Position

Does Cambridge Financial Group, Inc. own Abbvie Inc (ABBV)? Yes — 37.2K shares worth $8M (+3.02% of its 13F portfolio) as of Q1 2026, up from 36.8K shares the prior filed quarter.

Position Value
$8M
Q1 2026
Shares
37.2K
% of Portfolio
+3.02%
Quarters Held
12
currently held

Position History ABBV

Reported value by quarter
Q3 ’22: $4.5BQ3 ’22Q4 ’22: $5MQ3 ’23: $5MQ3 ’23Q4 ’23: $5MQ1 ’24: $6MQ1 ’24Q2 ’24: $6MQ4 ’24: $7MQ4 ’24Q1 ’25: $8MQ2 ’25: $5MQ2 ’25Q3 ’25: $9MQ4 ’25: $8MQ4 ’25Q1 ’26: $8Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202637.2K$8M+3.02%
Q4 202536.8K$8M+3.21%
Q3 202537.7K$9M+3.39%
Q2 202527.3K$5M+2.56%
Q1 202538.0K$8M+3.46%
Q4 202438.3K$7M+2.81%
Q2 202436.0K$6M+2.77%
Q1 202433.7K$6M+2.72%
Q4 202331.7K$5M+2.46%
Q3 202334.3K$5M+2.79%
Q4 202231.5K$5M+2.84%
Q3 202233.6K$4.5B+2.71%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Cambridge Financial Group, Inc.’s full portfolio or all institutional holders of ABBV.